In the biggest opioid case to date, Purdue Pharma, manufacturer of OxyContin, reached a tentative settlement last month with 23 states and attorneys representing roughly 2,000 local governments. The deal would have Purdue Pharma file for bankruptcy, which the company did recently, and pay as much as $12 billion over time, with up to $4.5 billion coming from the Sackler family, which owns the company. That number involves future profits and the value of drugs currently in development.
This article is restricted per publishing limits. Soon we will offer the ability to buy the ability to read this content.